维生素D对于女性泌尿生殖道沙眼衣原体感染治疗疗效的探讨
The Therapeutic Efficacy of Vitamin D in the Treatment of Chlamydia trachomatis Infection of the Genitourinary Tract in Women
DOI: 10.12677/jcpm.2024.33093, PDF,   
作者: 司晓辉, 樊家岚*:江苏大学附属澳洋医院妇科,江苏 张家港
关键词: 维生素D沙眼衣原体Vitamin D Chlamydia trachomatis
摘要: 目的:研究维生素D对于女性泌尿生殖道沙眼衣原体感染的应用疗效分析。方法:搜集2023年1月至2024年1月就诊于我院的检测出沙眼衣原体阳性的患者40名,同时选择健康的志愿者40名作为对照组。分别抽取两组患者的血清羟基维生素D(25-(OH)D)的浓度进行对比,其中感染组的患者抽取血清前未进行相关治疗;对感染组患者进行治疗结束后的1个月的血清羟基维生素D(25-(OH)D)的浓度进行检测,对比治愈患者前后血清羟基维生素D(25-(OH)D)的浓度。结果:① CT感染组与健康组的血清25-(OH)D水平进行对比,两组间比较差异有统计学意义(P < 0.05),而两组间年龄、BMI数值对比,差异无统计学意义(P > 0.05);② 将治愈患者与未治愈患者的血清25-(OH)D水平进行对比,治愈患者血清25-(OH)D水平为41.37 ± 21.03,未治愈患者血清25-(OH)D水平为29.47 ± 16.66,两组间比较差异有统计学意义(P < 0.05);③ 病例对照研究显示与维生素D > 50 nmol/L者相比维生素D水平缺乏者的调整OR = 7.188,95%CI: 2.462, 21.147。结论:人泌尿生殖道沙眼衣原体感染及疗效降低与维生素D缺乏相关,血清维生素D水平降低可能会增加泌尿生殖道沙眼衣原体感染风险,并降低疗效。
Abstract: Purpose: Study of the efficacy of vitamin D in the application of Chlamydia trachomatis infection of the genitourinary tract in women. Method: Forty patients who tested positive for Chlamydia trachomatis and 40 healthy volunteers were collected from January 2023 to January 2024, and 40 healthy volunteers were selected as the control group. The serum hydroxyvitamin D (25-(OH)D) concentrations of the two groups of patients were extracted for comparison, in which the patients in the infected group did not undergo any relevant treatment before serum extraction; the serum hydroxyvitamin D(25-(OH)D) one month after the completion of treatment, and ere compared between before and after the cure of the patients. Result: ① The serum 25-(OH)D levels of the CT infected group were compared with those of the healthy group, statistically significant (P < 0.05), whereas the difference between the two groups was not statistically significant when comparing; ② The serum 25-(OH)D levels of the cured patients were compared with those of the untreated patients, the serum 25-(OH)D levels of the cured patients were 41.37 ± 21.03 in cured patients and 29.47 ± 16.66 in non-cured patients, and the difference between the two groups was statistically significant; ③ The case-control study showed that the adjusted OR = 7.188, 95%CI: 2.462, 21.147 in vitamin D deficient patients compared to those with vitamin D > 50 nmol/L. Conclusion: Human genitourinary Chlamydia trachomatis infection and reduced efficacy are associated with vitamin D deficiency, and reduced serum vitamin D levels may increase the risk of genitourinary Chlamydia trachomatis infection and reduce efficacy.
文章引用:司晓辉, 樊家岚. 维生素D对于女性泌尿生殖道沙眼衣原体感染治疗疗效的探讨[J]. 临床个性化医学, 2024, 3(3): 653-657. https://doi.org/10.12677/jcpm.2024.33093

参考文献

[1] Taira, T., Broussard, N. and Bugg, C. (2022) Pelvic Inflammatory Disease: Diagnosis and Treatment in the Emergency Department. Emergency Medicine Practice, 24, 1-24.
[2] 李会平, 霍新年. 不孕不育夫妇生殖道解脲支原体、沙眼衣原体感染及抗精子抗体、抗子宫内膜抗体关系探讨[J]. 中国优生与遗传杂志, 2014, 23(7): 108-109.
[3] 柳雨雨, 袁涛, 李海鸿, 等. 维生素D治疗多囊卵巢综合征有效性的meta分析[J]. 中国循证医学杂志, 2020, 20(6): 81-87.
[4] 张婷婷, 杨君, 王慧玲. 血清维生素D和C-反应蛋白水平与多囊卵巢综合征发病的相关性分析[J]. 新乡医学院学报, 2021, 38(10): 949-952.
[5] 杨伟杰, 赵伟盘, 刘永亮. 等维生素D受体研究进展[J]. 河南科技学院学报(自然科学版), 2019, 47(5): 46-51.
[6] 曹蕾, 上官改珍, 白露. 1,25-(OH)2D3在宫颈良性病变和宫颈癌患者中的表达水平及临床意义[J]. 实用癌症杂志, 2019, 34(9): 1409-1411.
[7] 尹俊杨, 叶元. 维生素D及其受体在妇科癌症中的研究进展[J]. 现代肿瘤医学, 2022, 30(6): 1129-1132.
[8] 韦成厚, 韩立薇, 张婧, 等. 维生素D在子宫内膜异位症免疫发病机制中的作用研究[J]. 中国现代医药杂志, 2022(8): 19-22.
[9] 王子豪, 周建政, 王美霎, 等. 子宫肌瘤与维生素D关系的研究进展[J]. 国际妇产科学杂志, 2021(5): 543-547.
[10] 刘彩霞. 高剂量维生素D补充剂对绝经后骨质疏松症患者骨代谢标志物、骨密度的影响[J]. 妇儿健康导刊, 2024(3): 22-24, 28.
[11] Gembillo, G., Cernaro, V., Salvo, A., Siligato, R., Laudani, A., Buemi, M., et al. (2019) Role of Vitamin D Status in Diabetic Patients with Renal Disease. Medicina, 55, Article No. 273. [Google Scholar] [CrossRef] [PubMed]
[12] Ramanathan, B., Davis, E.G., Ross, C.R. and Blecha, F. (2002) Cathelicidins: Microbicidal Activity, Mechanisms of Action, and Roles in Innate Immunity. Microbes and Infection, 4, 361-372. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, T., Nestel, F.P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., et al. (2004) Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression. The Journal of Immunology, 173, 2909-2912. [Google Scholar] [CrossRef] [PubMed]
[14] Gombart, A.F., Borregaard, N. and Koeffler, H.P. (2005) Human Cathelicidin Antimicrobial Peptide (CAMP) Gene Is a Direct Target of the Vitamin D Receptor and Is Strongly Up‐Regulated in Myeloid Cells by 1,25‐Dihydroxyvitamin D3. The FASEB Journal, 19, 1067-1077. [Google Scholar] [CrossRef] [PubMed]
[15] Christakos, S., Dhawan, P., Liu, Y., Peng, X. and Porta, A. (2003) New Insights into the Mechanisms of Vitamin D Action. Journal of Cellular Biochemistry, 88, 695-705. [Google Scholar] [CrossRef] [PubMed]
[16] Adams, J.S., Ren, S., Liu, P.T., Chun, R.F., Lagishetty, V., Gombart, A.F., et al. (2009) Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses. The Journal of Immunology, 182, 4289-4295. [Google Scholar] [CrossRef] [PubMed]